Patents Assigned to Meiji Milk Products, Co., Ltd.
  • Patent number: 7112329
    Abstract: The T-cell epitope site on a Japanese cypress (hinoki) pollen allergen molecule has been identified by stimulating a T-cell line established from a patient suffering from Japanese cypress pollen allergy with an overlap peptide covering the primary structure of the Japanese cypress pollen allergen. The peptide is useful in peptide-based immunotherapy for patients with spring tree pollinosis including patients with Japanese cypress pollinosis having cross reactivity with Japanese cypress pollen. The peptide is also useful for diagnosing spring tree pollinosis.
    Type: Grant
    Filed: June 12, 1997
    Date of Patent: September 26, 2006
    Assignee: Meiji Milk Products Co. Ltd.
    Inventors: Kohsuke Kino, Kazuo Dairiki
  • Patent number: 6719976
    Abstract: The present invention provides a monomolecular multi-epitope peptide prepared by binding T cell epitope regions derived from different allergen molecules with each other. A peptide-based immunotherapeutic agent containing an effective amount of the multi-epitope peptide can treat a wide range of allergic diseases.
    Type: Grant
    Filed: September 9, 1998
    Date of Patent: April 13, 2004
    Assignee: Meiji Milk Products Co., Ltd.
    Inventors: Toshio Sone, Akinori Kume, Kazuo Dairiki, Akiko Iwama, Kohsuke Kino
  • Publication number: 20020132984
    Abstract: The present invention provides novel use of the MK family that is used alone as an agent for proliferating hematopoietic stem cells and hematopoietic precursor cells. The invention also provides an agent for remarkably enhancing the above-described effect for promoting the proliferation of hematopoietic stem cells and hematopoietic precursor cells, comprising the MK family in combination with known hematopoietic factors such as IL-3, IL-6, G-CSF, GM-CSF, M-CSF, SCF, and EPO.
    Type: Application
    Filed: February 8, 2002
    Publication date: September 19, 2002
    Applicant: Meiji Milk Products Co., Ltd.
    Inventors: Makoto Kikuchi, Shinva Ikematsu, Munehiro Oda, Sadatoshi Sakuma, Takashi Muramatsu
  • Patent number: 6451351
    Abstract: A method for preparing a gel composition, such as alginate gel beads, using a proper concentration of calcium pantothenate or calcium ascorbate as a gelling agent.
    Type: Grant
    Filed: July 3, 2000
    Date of Patent: September 17, 2002
    Assignees: Meiji Milk Products Co., Ltd.
    Inventors: Susumu Kawashima, Yoshifumi Murata
  • Patent number: 6383480
    Abstract: The present invention provides novel use of the MK family that is used alone as an agent for proliferating hematopoietic stem cells and hematopoietic precursor cells. The invention also provides an agent for remarkably enhancing the above-described effect for promoting the proliferation of hematopoietic stem cells and hematopoietic precursor cells, comprising the MK family in combination with known hematopoietic factors such as IL-3, IL-6, G-CSF, GM-CSF, M-CSF, SCF, and EPO.
    Type: Grant
    Filed: January 7, 1999
    Date of Patent: May 7, 2002
    Assignee: Meiji Milk Products, Co., Ltd.
    Inventors: Makoto Kikuchi, Shinya Ikematsu, Munehiro Oda, Sadatoshi Sakuma, Takashi Muramatsu
  • Patent number: 6337322
    Abstract: Preventives and remedies for intestinal mucosal disorders and diseases caused thereby which contain as the active ingredient a member selected from the group consisting of ethanolamine, phosphoethanolamine, phosphoglycerolethanolamine and salts thereof. These preventives and remedies inhibit shrinkage of the intestinal mucosa and have a beneficial effect on various functions of the intestinal tract.
    Type: Grant
    Filed: October 2, 2000
    Date of Patent: January 8, 2002
    Assignee: Meiji Milk Products Co., Ltd.
    Inventors: Hajime Sasaki, Kenji Mizumoto, Hisae Kume
  • Patent number: 6287757
    Abstract: An amino acid-trehalose composition comprising an amino acid composition which comprises proline, alanine, glycine, valine, threonine, leucine, histidine, lysine, isoleucine, arginine, phenylalanine, tyrosine, and tryptophan; and trehalose. The amino acid-trehalose composition has effects of compensating the reduction of the blood level of amino acids associated with severe exercise, of improving the exercise, of reducing the degree of fatigue after exercise and of recovering from fatigue. In addition, the administration of the composition permits the inhibition of the consumption of amino acids associated with exercise and any induction of fatigue accompanied by exercise.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: September 11, 2001
    Assignees: Riken, Meiji Milk Products Co., Ltd.
    Inventors: Takashi Abe, Koji Iida, Hiroshi Tsuchita
  • Patent number: 6284745
    Abstract: The present invention provides a sustained-release composition obtained by gelating a compound such as a drug together with an oil or polysaccharide. This composition enables excellent sustained release of a contained compound such as a drug. Orally administered, the gel composition can stay in the stomach for a prolonged period by adjusting its specific gravity by varying the amount of oil or polysaccharide in the composition.
    Type: Grant
    Filed: September 14, 1999
    Date of Patent: September 4, 2001
    Assignee: Meiji Milk Products Co., Ltd.
    Inventors: Susumu Kawashima, Yoshifumi Murata
  • Patent number: 6228893
    Abstract: Described is a cyclohexenone long-chain alcohol represented by the formula (1): wherein R1, R2 and R3 each independently represents a hydrogen atom or a methyl group and X represents a C10-18 alkylene or alkenylene group. The cyclohexanone long-chain alcohol according to the present invention has excellent neurite growth stimulating effects and is therefore useful as a preventive and/or therapeutic agent for Alzheimer's disease.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: May 8, 2001
    Assignee: Meiji Milk Products Co., Ltd.
    Inventors: Bang Luu, Gaby Schmitt, Florence Keyling, Celine Junges-Girlanda, Masashi Yamada, Yukie Suma
  • Patent number: 6224861
    Abstract: An amino acid composition comprising the following amino acids at the following molar ratio: proline (12.6 to 23.4), alanine (8.4 to 15.6), glycine (13.3 to 24.9), valine (8.2 to 15.4), threonine (5.0 to 9.4), eucine (4.3 to 8.1), histidine (1.8 to 11.9), serine (1.7 to 3.3), lysine (6.0 to 11.2), isoleucine (3.1 to 5.9), glutamic acid (2.2 to 10.4), arginine (2.4 to 4.6), phenylalanine (2.6 to 5.0), tyrosine (4.2 to 7.8) and trypsin (1.5 to 2.9). The composition supplements blood amino acids reduced during hard exercise and shows effects to improve motor function, to reduce fatigue after exercise and to help recovery from the fatigue.
    Type: Grant
    Filed: July 9, 1998
    Date of Patent: May 1, 2001
    Assignees: The Institute of Physical and Chemical Research., Meiji Milk Products Co., Ltd.
    Inventors: Takashi Abe, Hiroshi Tsuchita, Koji Iida
  • Patent number: 6180400
    Abstract: A method of culturing avian cells in a medium with a pH value of 7.8 or above, whereby avian cells can be subcultured stably for long. Since avian cells have been incapable of subculture heretofore, it has been impossible to effect in vitro cell or gene manipulation therewith. Now that such a manipulation becomes possible by the invention method, the way is opened for the industrial utilization of avian cells in the creation of transgenic birds and the production of vaccines.
    Type: Grant
    Filed: May 1, 1997
    Date of Patent: January 30, 2001
    Assignee: Meiji Milk Products, Co., Ltd.
    Inventors: Takashi Kuwana, Koichiro Hashimoto, Akira Nakanishi
  • Patent number: 6083907
    Abstract: An anti-ulcer composition is provided, which comprises as an active ingredient at least one of MK protein, its derivative having biological activity of MK protein, and their fragment having biological activity of MK protein, and a pharmaceutically acceptable carrier. The composition exhibits an effect for treating ulcer by promoting autotherapy without recurrence of ulcer.
    Type: Grant
    Filed: January 22, 1998
    Date of Patent: July 4, 2000
    Assignee: Meiji Milk Products Co., Ltd.
    Inventors: Masayuki Uchida, Shinya Ikematsu, Minehiko Yokoyama, Akio Yamashita, Hideshi Kumai, Munehiro Oda, Naoki Kato, Sadatoshi Sakuma, Takashi Muramatsu
  • Patent number: 5972914
    Abstract: The present invention discloses a method for the treatment of liver diseases, comprising administering an effective amount of an aminoalcohol of the following formula (1) or a salt thereof: ##STR1## wherein R.sup.1 represents a hydrogen atom or a phosphono group, R.sup.2 represents a hydrogen atom or a group --(CH.sub.2).sub.n --OR.sup.1, and n represents an integer between 2 and 5 inclusive. The present invention also relates to the use of the compound in the manufacture of a remedy for the treatment of liver diseases. This compound exhibits hepatocyte proliferation activity and liver disorder restoring effect, and thus is useful for the treatment of acute hepatitis, chronic hepatitis, hepatic cirrhosis, etc.
    Type: Grant
    Filed: July 20, 1998
    Date of Patent: October 26, 1999
    Assignee: Meiji Milk Products Co., Ltd.
    Inventors: Hajime Sasaki, Atsushi Nemoto, Hisae Kume, Hiroshi Tsuboi, Kenji Mizumoto, Naommy Takahashi, Masayuki Uchida
  • Patent number: 5932271
    Abstract: Fabricated rice containing whey protein in the range of 0.1-10% by weight, and optionally sodium alginate and calcium, and a process for preparing the same by mixing starches, whey protein(s), and optionally sodium alginate and a calcium salt with water, followed by heating and shaping.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 3, 1999
    Assignee: Meiji Milk Products, Co., Ltd.
    Inventors: Kaoru Koide, Takashi Fukushima, Takao Tomita, Tamotsu Kuwata
  • Patent number: 5916924
    Abstract: The present invention discloses a method for the treatment of liver diseases, comprising administering an effective amount of an aminoalcohol of the following formula (1) or a salt thereof: ##STR1## wherein R.sup.1 represents a hydrogen atom or a phosphono group, R.sup.2 represents a hydrogen atom or a group--(CH.sub.2).sub.n --OR.sup.1, and n represents an integer between 2 and 5 inclusive. The present invention also relates to the use of the compound in the manufacture of a remedy for the treatment of liver diseases. This compound exhibits hepatocyte proliferation activity and liver disorder restoring effect, and thus is useful for the treatment of acute hepatitis, chronic hepatitis, hepatic cirrhosis, etc.
    Type: Grant
    Filed: November 17, 1997
    Date of Patent: June 29, 1999
    Assignee: Meiji Milk Products Co., Ltd.
    Inventors: Hajime Sasaki, Atsushi Nemoto, Hisae Kume, Hiroshi Tsuboi, Kenji Mizumoto, Naommy Takahashi, Masayuki Uchida
  • Patent number: 5792793
    Abstract: The present invention relates to a complex formed by the coordination between a thiol group-containing compound and a silver ion; an antibacterial, antifungal, and antiviral agent containing the same as the active agent; and an antibacterial, antifungal, and antiviral composition containing the above agent and a vehicle or a carrier.The agent has a wide antibacterial and antifungal spectrum and an antiviral activity, is well compatible with various vehicles and carriers, sustains its activity for long, and has reduced peroral toxicity, skin irritation and mucosa irritation.
    Type: Grant
    Filed: May 6, 1996
    Date of Patent: August 11, 1998
    Assignees: Meiji Milk Products Co., Ltd., Toyo Ink Mfg. Co., Ltd.
    Inventors: Munehiro Oda, Hiroyuki Itoh, Tetsushi Sudo, Sadatoshi Sakuma, Kenji Nomiya, Yasunori Suzuki, Yukiyoshi Jonoshita, Akira Kikuchi, Yoshiko Takabatake
  • Patent number: 5747310
    Abstract: A gene to be integrated is bound to pAM.beta.1 plasmid to construct an integration plasmid, which is conjugally transferred into chromosomal DNA of a strain of Lactobacillus delbrueckii species. Integration of only the objective gene occurs through homologous recombination events (double crossing-over). According to this method, an arbitrary gene can be integrated into chromosomal DNA of a strain of Lactobacillus delbrueckii species and the DNA sequence derived from the vector, pAM.beta.1, can be completely removed. Therefore, the obtained gene integrant is widely applicable to the production of foods, medicines, feeds and the like.
    Type: Grant
    Filed: December 4, 1996
    Date of Patent: May 5, 1998
    Assignee: Meiji Milk Products Co., Ltd.
    Inventors: Takashi Sasaki, Yasuko Sasaki, Yoshiyuki Ito, Kumi Otsu
  • Patent number: 5693629
    Abstract: A progesterone compound represented by the following formula (1): ##STR1## ?wherein R.sup.1 represents a C1-C23 hydrocarbon group!, and a neovascularization inhibitor containing the same as the active ingredient.The compound (1) has a potent neovascularization inhibitory effect and is hence useful in the treatment of malignant tumors, diabetic retinitis, rheumatism, etc.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: December 2, 1997
    Assignee: Meiji Milk Products Co., Ltd.
    Inventors: Satoshi Hibino, Eiichi Sugino, Tetsuya Kohno, Shiho Fujimori, Hideo Nemoto, Yoshitatsu Ichihara, Yoshio Sato
  • Patent number: 5629284
    Abstract: A method for treating retinal diseases includes administering an effective amount of midkine to patients suffering from retinal diseases. The method of the invention is effective in ameliorating optical disorders of retinas and is quite safe.
    Type: Grant
    Filed: July 24, 1995
    Date of Patent: May 13, 1997
    Assignee: Meiji Milk Products Co., Ltd.
    Inventors: Kazuhiko Unoki, Hitoshi Arimura, Akiko Okubo, Norio Ohba, Takashi Muramatsu, Hisako Muramatsu
  • Patent number: 5629198
    Abstract: The invention relates to an anti-HIV agent comprising, as an active ingredient, at least one porphyrin derivative selected from the following derivatives (A) and (B):(A) porphyrins modified with a compound selected from carbodiimides, alkylenediamines and alcohols; and(B) complexes of a plasma protein or a chemically modified plasma protein and a porphyrin which may have been modified with a compound selected from carbodiimides, alkylenediamines and alcohols.This anti-HIV agent is excellent in killing effect on HIV-infected cells, inhibitory effect on cytopathy due to HIV infection and HIV-replication inhibiting effect, and high in safety.
    Type: Grant
    Filed: January 12, 1994
    Date of Patent: May 13, 1997
    Assignee: Meiji Milk Products Co., Ltd.
    Inventors: Kenji Mizumoto, Hiroshi Tsuboi, Hideki Miyajima, Hiroshi Fujimoto, Katsumi Ajisaka, Yukio Fujiki, Hajime Tsunoo